Literature DB >> 1003632

Use of hemiacidrin in management of infection stones.

N J Nemoy, T A Stamey.   

Abstract

Unless all fragments are removed at the time of surgery for struvite stones a high incidence of recurrent infection and stone formation is likely. To reduce the recurrence rate of such stones the renal pelvis is irrigated postoperatively with 10 per cent hemiacidrin solution for at least 48 hours or until all fragments have been dissolved. We have managed successfully 35 patients (36 kidneys) without enxountering any complications. Included in our most recent series are 2 patients with solitary kidneys who had successful dissolution of stone fragments. Absolute contraindications to the use of hemiacidrin are infected urine, fever or flank discomfort. Although we have found hemiacidrin dissolution of renal stones to be safe and effective it is essential that the clinician be aware of the proper technique and its possible complications.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003632     DOI: 10.1016/s0022-5347(17)58974-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Bacterial calcification in infective endocarditis.

Authors:  D N Poller; A Curry; L A Ganguli; R C Routledge
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

2.  Urothelial injury to the rabbit bladder caused by calcium dissolving agents including two new citrate solutions.

Authors:  Xiang-bo Zhang; Zhi-ping Wang; Jian-min Duan; Guo-lan Duan; Ting-kai Shi; Jian-zhong Lu; Bao-liang Ma
Journal:  Urol Res       Date:  2005-07-08

3.  Kidney stones.

Authors:  C R Kleeman; J W Coburn; A S Brickman; D B Lee; R G Narins; R M Ehrlich
Journal:  West J Med       Date:  1980-04

4.  New chemolysis for urological calcium phosphate calculi - a study in vitro.

Authors:  Zhang Xiang-bo; Wang Zhi-ping; Duan Jian-min; Lu Jian-zhong; Ma Bao-liang
Journal:  BMC Urol       Date:  2005-05-22       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.